|
November 16, 2019: Dr. John McMurray and Dr. C. Michael Gibson Discuss: DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in He |
Dr. John McMurray and Dr. C. Michael Gibson Discuss: DAPA-HF: The Dapagliflozin and Prevention of Adverse-Outcomes in Heart Failure Trial (DAPA-HF): Results in Nondiabetic Patients
TBA
[ Download video ] |
|
No comments have been submitted
|